Nexpoint Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Nexpoint Asset Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,979	Closed	-$545K	–	213
2021 Q4	$545K	Hold	54,979	–	–	0.08%	125
2021 Q3	$544K	Hold	54,979	–	–	0.09%	104
2021 Q2	$539K	Buy	+54,979	New	+$536K	0.12%	90

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCMH

Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

Nexpoint Asset Management's GRNA Position: Q1 2022 in Review

Nexpoint Asset Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2022, closing a stake of 54,979 shares — an estimated $545K sold.

Nexpoint Asset Management first reported a position in GRNA in Q2 2021 and held it in 3 quarters. The position peaked at $545K in Q4 2021. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

Nexpoint Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2022 after selling out during the quarter.
Nexpoint Asset Management sold 54,979 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2022, an estimated $545K.
Nexpoint Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 3 quarters.
Nexpoint Asset Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $545K in Q4 2021.
39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.